-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GSuXt6bpU9jvicLQrMV1mrn43VqzJh01ziNfzeVaHydKKkLxKQ1WASod9mTGzsfN /rmWZPZ3m1Lt/1zfOhOQzg== 0000069499-07-000009.txt : 20070216 0000069499-07-000009.hdr.sgml : 20070216 20070216170828 ACCESSION NUMBER: 0000069499-07-000009 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070214 FILED AS OF DATE: 20070216 DATE AS OF CHANGE: 20070216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KORMAN HARRY CENTRAL INDEX KEY: 0001197548 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09114 FILM NUMBER: 07632214 MAIL ADDRESS: STREET 1: MYLAN LABORATORIES INC STREET 2: 1718 NORTHROCK CT CITY: ROCKFORD STATE: IL ZIP: 61103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MYLAN LABORATORIES INC CENTRAL INDEX KEY: 0000069499 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 251211621 STATE OF INCORPORATION: PA FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 1500 CORPORATE DRIVE STREET 2: SUITE 400 CITY: CANONSBURG STATE: PA ZIP: 15317 BUSINESS PHONE: 724-514-1800 MAIL ADDRESS: STREET 1: 1500 CORPORATE DRIVE STREET 2: SUITE 400 CITY: CANONSBURG STATE: PA ZIP: 15317 FORMER COMPANY: FORMER CONFORMED NAME: FRM CORP DATE OF NAME CHANGE: 19711003 4 1 primary_doc.xml PRIMARY DOCUMENT X0202 4 2007-02-14 0 0000069499 MYLAN LABORATORIES INC MYL 0001197548 KORMAN HARRY MYLAN PHARMACEUTICALS INC. 781 CHESTNUT RIDGE RD. MORGANTOWN WV 26505 0 1 0 0 Pres., Mylan Pharmaceuticals Common Stock 2007-02-14 4 F 0 1476 21.91 D 15272 D Represents withholding of shares for the tax liability associated with the vesting of time-based restricted stock granted on February 15, 2006. In addition, the reporting person's indirect ownership through 401(K) holdings as of 02/13/2007 was 970 shares. /s/ Harry A. Korman 2007-02-16 -----END PRIVACY-ENHANCED MESSAGE-----